Parabilis Medicines, Inc. (PBLS)

36.32 -2.44 (-6.30%) USD  |  NASDAQ  |  Sep 10, 16:00
36.29 -0.03 (-0.08%) After-Hours: 20:00
More

Parabilis Medicines PS Ratio (Forward 1y)

PS Ratio (Forward 1y) Chart

View PS Ratio (Forward 1y) for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio (Forward 1y) Chart
Start Trial

Historical PS Ratio (Forward 1y) Data

View and export this data back to . Start Trial.
Date Value
September 10, 2026 --

Forward PS Ratio Definition

Forward Price to Sales Ratio is the current stock price over the predicted sales per share. While similar to the price to sales ratio, this is a forward looking estimate of a company's sales.

Read full definition.

PS Ratio (Forward 1y) Range, Past 5 Years

View PS Ratio (Forward 1y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio (Forward 1y) Benchmarks

View PS Ratio (Forward 1y) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Kailera Therapeutics, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. --